Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Genetron Holdings Limited GTH NASDAQ

NASDAQ Global Market • Healthcare • Medical - Diagnostics & Research • CN • USD

SharesGrow Score
47/100
1/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Genetron Holdings Limited (GTH) — Analyst outlook / Analyst consensus target is. Based on 2 analyst ratings, the consensus is bullish — 2 Buy.

GTH Analyst Ratings

Buy
2
Ratings
2 Buy
Based on 2 analysts giving stock ratings to Genetron Holdings Limited in the past 3 months
Rating breakdown
Buy
2 100%
100%
Buy
2 analysts
0%
Hold
0 analysts
0%
Sell
0 analysts

People Also View

SHC
SHC
Sotera Health Company
$15.93
+1.46%
 OLK
OLK
Olink Holding AB (publ)
$26.08
+0.31%
 CSTL
CSTL
Castle Biosciences, Inc.
$24.37
+3.57%
 ACRS
ACRS
Aclaris Therapeutics, Inc.
$3.92
+0.51%
 PRE
PRE
Prenetics Global Limited
$18.01
-0.88%
 MDXH
MDXH
MDxHealth SA
$2.27
+6.07%
 FONR
FONR
FONAR Corporation
$18.76
+0.27%
 BDSX
BDSX
Biodesix, Inc.
$12.14
-9.13%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message